Bliss GVS Pharma Limited

NSEI:BLISSGVS Stock Report

Market Cap: ₹17.0b

Bliss GVS Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BLISSGVS?
Owner TypeNumber of SharesOwnership Percentage
State or Government2,498,9102.37%
Institutions13,092,03912.4%
Private Companies15,077,60314.3%
General Public27,467,66326.1%
Individual Insiders47,195,80744.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 22 shareholders own 73.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30.7%
Shibroor Kamath
32,337,024₹5.2b1.19%no data
8.77%
Arian Investment Limited
9,240,603₹1.5b-1.7%no data
6.55%
Life Insurance Corporation of India, Asset Management Arm
6,901,355₹1.1b0%0.01%
5.54%
Gulbarga Trading & Investments Pvt. Ltd.
5,837,000₹940.0m0%no data
4.79%
Arjun Ashra
5,049,000₹813.1m0%no data
2.8%
Gautam Ashra
2,951,571₹475.4m-0.51%no data
2.37%
Investor Education and Protection Fund (IEPF)
2,498,910₹402.4m0%no data
2.35%
Vibha Sharma
2,475,000₹398.6m0%no data
2%
Shruti Vishal Rao
2,110,000₹339.8m0%no data
1.8%
FMR LLC
1,900,555₹306.1m0%no data
1.77%
COEUS Global Opportunities Fund
1,859,594₹299.5m0%9.09%
1.33%
Aurisse International Limited Asset Management Arm
1,404,022₹226.1m0%75.21%
1.14%
Dishant Parikh
1,198,062₹192.9m0%no data
0.96%
Bhupesh Lodha
1,010,000₹162.7m0%no data
0.56%
Aegis Investment Fund
590,536₹95.1m0%2.27%
0.38%
Dimensional Fund Advisors LP
400,841₹64.6m2.34%no data
0.031%
American Century Investment Management Inc
32,764₹5.3m0%no data
0.031%
Ramadas Kamath
32,188₹5.2m0%no data
0.024%
Punita Sharma
24,962₹4.0m0%no data
0.0076%
Shibroor Kamath
8,000₹1.3m0%no data
0.0014%
Motilal Oswal Asset Management Company Limited
1,462₹235.8k37.3%no data
0.00086%
Bandhan AMC Limited
910₹145.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 06:09
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bliss GVS Pharma Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research
Anil BurraFirstCall Research